Navigation Links
Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
Date:4/26/2008

n innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the IDEAL study and the potential market for PEGINTRON and REBETOL. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part I, Item 1A. "Risk Factors" in Schering-Plough's 2007 10-K/A.

Endnotes:

1 Pegasys and Copegus are registered trademarks of Hoffmann-La Roche Inc.

Please see the Pegasys and Copegus product inserts for information on

these products.'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
2. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
3. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
4. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
5. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
9. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
11. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 LifeNet Health plans to enlarge its ... to more than 160 people. The organization,s ... Health,s innovative bio-implants, which are being made more widely ... served. It also is a reflection of the region,s ... growth and success of LifeNet Health is a great ...
(Date:5/29/2015)... MENLO PARK, Calif. , May ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, presented ... of Cancer Research (AACR) Advances in Brain Cancer ... lead product candidate VAL-083 (dianhydrogalactitol) to ...
(Date:5/29/2015)... Pa. , May 29, 2015 ... focus of the Association for the Advancement of ... With support from AAWC,s corporate partners, ... Educational Portal on the AAWC website at ... a wound care pathway with links to various ...
Breaking Medicine Technology:LifeNet Health to add more than 160 jobs in 2015 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5The Association for the Advancement of Wound Care Educates the Public 2
... OrthoAccel Technologies, Inc. announced that it has entered into a partnership with ... System to the Australian market. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ) , , ... acceleration device to enhance orthodontics, was introduced to the United Kingdom ...
... a new market research report is available in its catalogue: , , , ... , , http://www.reportlinker.com/p0187226/The-World-Anesthesia-Drug-Market.html , ... report - The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: , ... , , , , ...
Cached Medicine Technology:OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction 2OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction 3OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction 4Reportlinker Adds The World Anesthesia Drug Market 2Reportlinker Adds The World Anesthesia Drug Market 3Reportlinker Adds The World Anesthesia Drug Market 4Reportlinker Adds The World Anesthesia Drug Market 5Reportlinker Adds The World Anesthesia Drug Market 6Reportlinker Adds The World Anesthesia Drug Market 7Reportlinker Adds The World Anesthesia Drug Market 8Reportlinker Adds The World Anesthesia Drug Market 9Reportlinker Adds The World Anesthesia Drug Market 10
(Date:5/29/2015)... Health DataPalooza is a national conference that brings ... the most effective and innovative ways to use open ... by the Health Data Consortium, which is a collaboration ... develop the use of open healthcare data. Within ... in on how to actually put the ideas into ...
(Date:5/29/2015)... 29, 2015 An organizational consultant and ... is losing his memory and may be suffering from ... both his professional life and in his uncertain relationship ... a hob-knobbing career working with corporate and government movers ... as multiple family members around him are being diagnosed ...
(Date:5/29/2015)... The FCPX Colorist brings professional color grading tools ... curves, hue, saturation and color levels like never before without ... Each FCPX Colorist Tool installs into Final Cut ... Pro X Effects library. This modular set-up allows users to ... achieve endless looks. , FCPX Colorist introduces curve color correcting ...
(Date:5/29/2015)... 29, 2015 National Day of Sweden ... nationals around the world. The celebration held in Atlanta is ... cooperation with SWEA (Swedish Women’s Educational Association International, ... for the Swedish-American community in Georgia. , PartnerTech ... Swedish heritage and the long relationship between Sweden and Georgia. ...
(Date:5/29/2015)... May 28th, TheCelebrityDresses.com released their new range of exclusively ... of the styles in their new collection were priced ... styles of sexy cocktail dresses and 100 cheap bridesmaid ... with the new release are color blocks, exclusively designed ... the new styles are made of carefully selected fine ...
Breaking Medicine News(10 mins):Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2Health News:Announcing the Release of FCPX Colorist from Pixel Film Studios for Final Cut Pro X. 2Health News:PartnerTech Co-Sponsors National Sweden Day Hosted by SACC-Georgia 2Health News:PartnerTech Co-Sponsors National Sweden Day Hosted by SACC-Georgia 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2
... tumors, study found , WEDNESDAY, Feb. 10 (HealthDay News) -- ... spiritual thinking and feeling in patients, a finding that adds ... physical makeup of the mind, researchers say. , The findings, ... are based on research in patients who had surgery to ...
... 40 percent of women don,t know it is leading killer, ... public awareness campaigns, almost half of all American women still ... death in women, new research finds. , Even more concerning, ... emergency help if they were having heart attack symptoms, according ...
... , PUYALLUP, Wash. , Feb. 10 ... and the American Recovery and Reinvestment Act became household ... imaging and data management integration project with interoperability provider ... for MINW patients even after the completion of the ...
... with Inflammatory Bowel Disease (IBD) are known to be at high ... of their disease but now new research by scientists at The ... to hospital during flare-ups are also at risk. The two ... affect about one in every 250 people in the UK. The ...
... Annals of Surgical Oncology (ASO), the official journal ... additional society affiliation with the American Society of Breast ... ASO is a leading monthly publication that features original ... from all specialties. Dr. William Curtis, Executive Vice ...
... The NADA convention and ... , ... Auto dealers will be able to attend free workshops hosted by KPA and TK ... Convention and Expo 2010., , ,The free workshops will be in the NADA exhibit hall in ...
Cached Medicine News:Health News:Physical Changes in Brain Linked to Altered Spirituality 2Health News:Women's Heart Disease Awareness Still Lacking 2Health News:Women's Heart Disease Awareness Still Lacking 3Health News:Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements 2Health News:Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements 3Health News:Bowel disease link to blood clots 2Health News:Bowel disease link to blood clots 3Health News:Annals of Surgical Oncology adds new society affiliation 2Health News:KPA and TK Carsites offer HR, OSHA and Internet Marketing Workshops at the NADA Convention and Expo 2010 2
International version of the Twin Beam, it is BSI-, IEC-, CE- approved....
Cold light source single outlet....
Cold light source single outlet....
Cold light source triple outlet....
Medicine Products: